Benjamin F. Edwards & Company’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.36M | Buy |
60,913
+60,052
| +6,975% | +$1.34M | 0.02% | 450 |
|
|
2024
Q1 | $24K | Buy |
+861
| New | +$24K | ﹤0.01% | 1479 |
|
|
2022
Q4 | – | Sell |
-100
| Closed | -$6K | – | 1885 |
|
|
2022
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 1518 |
|
|
2022
Q2 | $5K | Sell |
100
-100
| -50% | -$5K | ﹤0.01% | 1551 |
|
|
2022
Q1 | $15K | Hold |
200
| – | – | ﹤0.01% | 1286 |
|
|
2021
Q4 | $24K | Buy |
+200
| New | +$24K | ﹤0.01% | 1197 |
|
|
2020
Q4 | – | Sell |
-550
| Closed | -$11K | – | 1706 |
|
|
2020
Q3 | $11K | Hold |
550
| – | – | ﹤0.01% | 1256 |
|
|
2020
Q2 | $12K | Hold |
550
| – | – | ﹤0.01% | 1244 |
|
|
2020
Q1 | $7K | Hold |
550
| – | – | ﹤0.01% | 1372 |
|
|
2019
Q4 | $8K | Hold |
550
| – | – | ﹤0.01% | 1484 |
|
|
2019
Q3 | $7K | Sell |
550
-2,349
| -81% | -$29.9K | ﹤0.01% | 1497 |
|
|
2019
Q2 | $47K | Hold |
2,899
| – | – | ﹤0.01% | 920 |
|
|
2019
Q1 | $50K | Buy |
2,899
+600
| +26% | +$10.3K | ﹤0.01% | 873 |
|
|
2018
Q4 | $31K | Hold |
2,299
| – | – | ﹤0.01% | 962 |
|
|
2018
Q3 | $66K | Hold |
2,299
| – | – | 0.01% | 781 |
|
|
2018
Q2 | $63K | Buy |
2,299
+341
| +17% | +$9.34K | 0.01% | 786 |
|
|
2018
Q1 | $41K | Buy |
1,958
+671
| +52% | +$14.1K | ﹤0.01% | 891 |
|
|
2017
Q4 | $25K | Buy |
1,287
+425
| +49% | +$8.26K | ﹤0.01% | 954 |
|
|
2017
Q3 | $21K | Hold |
862
| – | – | ﹤0.01% | 964 |
|
|
2017
Q2 | $14K | Buy |
862
+312
| +57% | +$5.07K | ﹤0.01% | 977 |
|
|
2017
Q1 | $8K | Hold |
550
| – | – | ﹤0.01% | 1071 |
|
|
2016
Q4 | $7K | Hold |
550
| – | – | ﹤0.01% | 1009 |
|
|
2016
Q3 | $9K | Buy |
+550
| New | +$9K | ﹤0.01% | 868 |
|